全文获取类型
收费全文 | 108132篇 |
免费 | 6998篇 |
国内免费 | 1628篇 |
专业分类
耳鼻咽喉 | 1300篇 |
儿科学 | 2226篇 |
妇产科学 | 1428篇 |
基础医学 | 9866篇 |
口腔科学 | 13013篇 |
临床医学 | 8714篇 |
内科学 | 17302篇 |
皮肤病学 | 1851篇 |
神经病学 | 6268篇 |
特种医学 | 2368篇 |
外国民族医学 | 26篇 |
外科学 | 15400篇 |
综合类 | 8537篇 |
现状与发展 | 7篇 |
一般理论 | 5篇 |
预防医学 | 8280篇 |
眼科学 | 1460篇 |
药学 | 8205篇 |
57篇 | |
中国医学 | 3857篇 |
肿瘤学 | 6588篇 |
出版年
2023年 | 1346篇 |
2022年 | 1704篇 |
2021年 | 3901篇 |
2020年 | 3159篇 |
2019年 | 6893篇 |
2018年 | 7019篇 |
2017年 | 5132篇 |
2016年 | 2903篇 |
2015年 | 2724篇 |
2014年 | 4448篇 |
2013年 | 5021篇 |
2012年 | 3869篇 |
2011年 | 4220篇 |
2010年 | 3341篇 |
2009年 | 2958篇 |
2008年 | 2863篇 |
2007年 | 2931篇 |
2006年 | 2666篇 |
2005年 | 2395篇 |
2004年 | 2009篇 |
2003年 | 1829篇 |
2002年 | 1502篇 |
2001年 | 1478篇 |
2000年 | 1223篇 |
1999年 | 1035篇 |
1998年 | 861篇 |
1997年 | 854篇 |
1996年 | 685篇 |
1995年 | 671篇 |
1994年 | 625篇 |
1993年 | 454篇 |
1992年 | 477篇 |
1991年 | 432篇 |
1990年 | 337篇 |
1989年 | 360篇 |
1988年 | 284篇 |
1987年 | 281篇 |
1985年 | 3037篇 |
1984年 | 3530篇 |
1983年 | 2994篇 |
1982年 | 3475篇 |
1981年 | 3151篇 |
1980年 | 2621篇 |
1979年 | 2575篇 |
1978年 | 2139篇 |
1977年 | 1610篇 |
1976年 | 2058篇 |
1975年 | 1560篇 |
1974年 | 1354篇 |
1973年 | 1299篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Shylo R. Johnson Dennis Slate Kathleen M. Nelson Amy J. Davis Samual A. Mills John T. Forbes Kurt C. VerCauteren Amy T. Gilbert Richard B. Chipman 《Viruses》2021,13(2)
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination. This study describes the continuation of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2 corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations. Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727, 95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72, 95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated an increasing trend across study years for both bait densities and species, indicating that multiple years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife populations for the control and elimination of raccoon RV in the eastern USA. 相似文献
53.
俞海燕 《浙江中西医结合杂志》2019,29(10)
<正>机体的血钾参与并维持细胞代谢,保持细胞内液渗透压及酸碱平衡,并可维持神经肌肉组织兴奋及心肌功能~([1-2])。中重度低血钾主要表现为肌无力,可延及机体的躯干和呼吸肌,造成呼吸困难,还可引发腱反射减弱或消失、肠麻痹及心脏传导阻滞、节律异 相似文献
54.
55.
56.
目的:探讨建立一种放射治疗全身器官剂量数据库平台的可行性。方法:使用基于深度学习的自动勾画软件DeepViewer?1例食管癌患者的全身CT上勾画全身器官,然后利用基于GPU加速的蒙特卡罗软件ARCHER计算相应的器官剂量分布,最后利用Lyman-Kutcher-Burman(LKB)模型评估放疗患者正常组织并发症概率(NTCP)。结果:针对该病例,成功建立基于DeepViewer?ARCHER和LKB模型的全身器官剂量数据库,发现距离靶区越近的器官剂量越大,其中心脏与靶区间距离最小,剂量为14.11 Gy,但因其模型参数特殊,通过LKB模型计算的NTCP为0.00%;左、右肺的剂量分别为3.19和1.16 Gy,但是NTCP值却很大,分别为2.13%和1.60%。对于距离靶区较远的头颈部器官(视交叉、视神经和眼)和腹部器官(直肠、膀胱和股骨头)剂量分别约为9和2 mGy,并且NTCP均近似为0.00%。结论:研究结果证明通过自动勾画软件DeepViewer?蒙特卡罗软件ARCHER和LKB模型建立全身器官剂量数据库的可行性。 相似文献
57.
《Diagnostic Histopathology》2022,28(5):253-266
The epithelial remnants of tooth development give rise to an impressive range of cystic lesions, termed odontogenic cysts. They are classified based on their distinct clinical, radiological and histological features, a process that has not been without controversy. We will attempt to explain the basis of the debate behind the changing classification of odontogenic cysts, describing their aetiology, clinical and histological features, along with common pitfalls that can confuse the diagnostic process. More common diagnostic challenges, such as the effects of inflammation and mucous change, will be explored in detail. An attempt will be made to distil the diagnostic process into simple algorithmic steps to narrow down the differential diagnoses of this fascinating group of lesions. We will demonstrate the importance of careful consideration of the clinical and radiological features that can help prevent misclassification, ensuring appropriate management and follow-up for this diverse group of lesions. 相似文献
58.
《Injury》2019,50(5):1105-1110
IntroductionGetting the right patient, to the right place, at the right time is dependent on a multitude of modifiable and non-modifiable factors. One potentially modifiable factor is the number and location of trauma centres (TC). Overabundance of TC dilutes volumes and could be associated with worse outcomes. We describe a methodology that evaluates trauma system reconfiguration without reductions in potential access to care. We used the mature trauma system of New South Wales (NSW) as a model given the perceived overabundance of urban major trauma centres (MTC).MethodsWe first evaluated potential access to TC care via ground and air transport through the use of geographic information systems (GIS) network analysis. Potential access was defined as the proportion of the population living within 60-min transport time from a potential scene of injury to a TC by ground or rotary-wing aircraft. Sensitivity analyses were carried out in order to account for potential pre-hospital interventions and/or transport delays; travel times of 15-, 30-, 45-, 60-, and 90-min were also analyzed. We then evaluated if the current configuration of the system (number of urban MTS in the Sydney basin) could be optimized without reductions in potential access to care using two GIS methodologies: location-allocation and individual removal of MTC.Results86% of the NSW population has potential access to a TC within 60 min ground travel time; potential access improves to 99% with rotary-wing transport. The 1% of the population without potential TC access lives in 48% of the land area (>384,000km2). Utilizing two different methodologies we identified that there was no change in potential access by ground transport after removing 1 or 2 MTC in the Sydney basin at the 30-, 45-, and 60-min transport times. However, 0.02% and 0.5% of the population would not have potential access to MTC care at 15 min after removing one and two MTC respectively.DiscussionRedistribution of the number of MTC in the Sydney basin could be achieved without a significant impact on potential access to care. Our approach can be utilized as an initial tool to evaluate a trauma system where overabundance of coverage is present. 相似文献
59.
Ramya C. Mosarla Muthiah Vaduganathan Arman Qamar Javid Moslehi Gregory Piazza Robert P. Giugliano 《Journal of the American College of Cardiology》2019,73(11):1336-1349
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke prevention in patients with atrial fibrillation (AF). More recently, direct oral anticoagulants (DOACs) have been demonstrated to reduce the risk of venous and arterial thromboembolism in large randomized clinical trials of patients with VTE and AF, respectively, thus providing an attractive oral dosing option that does not require routine laboratory monitoring. In this review, we summarize available clinical trial data and guideline recommendations, and outline a practical approach to anticoagulation management of VTE and AF in cancer. 相似文献
60.
Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
《Sleep medicine》2021
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients. 相似文献